𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma

✍ Scribed by Molly Yancovitz; Nika Finelt; Melanie A. Warycha; Paul J. Christos; Madhu Mazumdar; Richard L. Shapiro; Anna C. Pavlick; Iman Osman; David Polsky; Russell S. Berman


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
106 KB
Volume
110
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND.

In patients with T1b‐T3b cutaneous melanoma the utility of radiologic imaging at the time of diagnosis is unclear. Whether initial imaging led to a change in stage or treatment plan was investigated.

METHODS.

The melanoma database was searched for patients with T1b‐T3b primary lesions, clinically N0, and asymptomatic for metastatic disease. Radiologic studies conducted before wide local excision ± sentinel lymph node biopsy as well as all further imaging and investigations were analyzed. Outcome measures included upstaging, change in initial surgical management, true‐positive, false‐positive, true‐negative, and false‐negative rates of each imaging modality.

RESULTS.

In all, 344 preoperative imaging studies (chest x‐ray [CXR], computed tomography [CT], positron emission tomography [PET]/CT) were performed on 158 patients, resulting in 49 findings suspicious for metastatic melanoma and 134 findings suggestive of nonmelanoma pathology. Only 1 of 344 (0.3%) studies, a PET/CT, correlated with confirmed metastatic melanoma. The false‐positive rates were CXR 5 of 7 (71.4%), chest CT 21 of 24 (87.5%), abdomen/pelvis CT 10 of 11 (90.9%), head CT 2 of 2 (100.0%), PET/CT 3 of 5 (60.0%). No patient was upstaged or had a change in initial surgical management based on preoperative imaging. The cost of all initial imaging and imaging to follow‐up abnormal findings was estimated as $555,308 for the 158 patients studied.

CONCLUSIONS.

Imaging at the time of initial diagnosis of T1b‐T3b, clinically N0, M0 melanoma was of low yield with a high false‐positive rate, and did not lead to upstaging or change in initial surgical management. These findings suggest that imaging of asymptomatic patients at the time of diagnosis may not be warranted. Cancer 2007. © 2007 American Cancer Society.


📜 SIMILAR VOLUMES


Optimal timing for in vivo 1H-MR spectro
✍ Tom W.J. Scheenen; Giulio Gambarota; Elisabeth Weiland; Dennis W.J. Klomp; Jurge 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 706 KB

## Abstract Proton MR spectroscopic imaging (^1^H‐MRSI) of the human prostate, which has an interesting clinical potential, may be improved by increasing the magnetic field strength from 1.5T to 3T. Both theoretical and practical considerations are necessary to optimize the pulse timing for spectro

Dual-frequency, dual-quadrature, birdcag
✍ Gary X. Shen; Fernando E. Boada; Keith R. Thulborn 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 862 KB

Rapid quantification of tissue metabolites in vivo by MRS or MRI can be achieved using dual-frequency RF coils with identical B1 field distributions at the observation frequencies of the metabolites and tissue water protons. Tissue sodium is used as an example for optimizing the dual-frequency, dual

B1 transmission-field inhomogeneity and
✍ Che A. Azlan; Pierluigi Di Giovanni; Trevor S. Ahearn; Scott I.K. Semple; Fiona 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

## Abstract ## Purpose: To quantify B~1~ transmission‐field inhomogeneity in breast imaging of normal volunteers at 3T using 3D T~1~‐weighted spoiled gradient echo and to assess the resulting errors in enhancement ratio (ER) measured in dynamic contrast‐enhanced MRI (DCE‐MRI) studies of the breast